451 related articles for article (PubMed ID: 33052454)
1. Urine NGAL and KIM-1: tubular injury markers in acute lymphoblastic leukemia survivors.
Latoch E; Konończuk K; Taranta-Janusz K; Muszyńska-Rosłan K; Szymczak E; Wasilewska A; Krawczuk-Rybak M
Cancer Chemother Pharmacol; 2020 Dec; 86(6):741-749. PubMed ID: 33052454
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin.
Ghadrdan E; Ebrahimpour S; Sadighi S; Chaibakhsh S; Jahangard-Rafsanjani Z
J Oncol Pharm Pract; 2020 Oct; 26(7):1643-1649. PubMed ID: 32046578
[TBL] [Abstract][Full Text] [Related]
3. Urine NGAL and KIM-1-Tubular Injury Biomarkers in Long-Term Survivors of Childhood Solid Tumors: A Cross-Sectional Study.
Latoch E; Konończuk K; Muszyńska-Rosłan K; Taranta-Janusz K; Wasilewska A; Szymczak E; Trochim J; Krawczuk-Rybak M
J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33494327
[TBL] [Abstract][Full Text] [Related]
4. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
[TBL] [Abstract][Full Text] [Related]
5. Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis.
Noyan A; Parmaksiz G; Dursun H; Ezer SS; Anarat R; Cengiz N
J Pediatr Urol; 2015 Oct; 11(5):249.e1-6. PubMed ID: 26096437
[TBL] [Abstract][Full Text] [Related]
6. The Tubular Damage Markers: Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 in Newborns with Intrauterine Growth Restriction.
Kamianowska M; Szczepański M; Kulikowska EE; Bebko B; Wasilewska A
Neonatology; 2019; 115(2):169-174. PubMed ID: 30513528
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Urinary Calprotectin, NGAL and KIM-1 in Chronic Kidney Disease.
Seibert FS; Sitz M; Passfall J; Haesner M; Laschinski P; Buhl M; Bauer F; Babel N; Pagonas N; Westhoff TH
Kidney Blood Press Res; 2018; 43(4):1255-1262. PubMed ID: 30078006
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of NGAL and KIM-1 for acute kidney injury in patients with scrub typhus.
Sun IO; Shin SH; Cho AY; Yoon HJ; Chang MY; Lee KY
PLoS One; 2017; 12(4):e0175890. PubMed ID: 28419138
[TBL] [Abstract][Full Text] [Related]
10. Urinary biomarkers in the early detection and follow-up of tubular injury in childhood urolithiasis.
Taşdemir M; Fuçucuoğlu D; Küçük SH; Erol M; Yiğit Ö; Bilge I
Clin Exp Nephrol; 2018 Feb; 22(1):133-141. PubMed ID: 28653226
[TBL] [Abstract][Full Text] [Related]
11. Serum and urinary NGAL but not KIM-1 raises in human postrenal AKI.
Urbschat A; Gauer S; Paulus P; Reissig M; Weipert C; Ramos-Lopez E; Hofmann R; Hadji P; Geiger H; Obermüller N
Eur J Clin Invest; 2014 Jul; 44(7):652-9. PubMed ID: 24837251
[TBL] [Abstract][Full Text] [Related]
12. Urinary calprotectin, NGAL, and KIM-1 in the differentiation of primarily inflammatory vs. non-inflammatory stable chronic kidney diseases.
Seibert FS; Sitz M; Passfall J; Haesner M; Laschinski P; Buhl M; Bauer F; Rohn B; Babel N; Westhoff TH
Ren Fail; 2021 Dec; 43(1):417-424. PubMed ID: 33663323
[TBL] [Abstract][Full Text] [Related]
13. Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.
Lobato GR; Lobato MR; Thomé FS; Veronese FV
Braz J Med Biol Res; 2017 Mar; 50(5):e6106. PubMed ID: 28380198
[TBL] [Abstract][Full Text] [Related]
14. KIM-1 and NGAL: new markers of obstructive nephropathy.
Wasilewska A; Taranta-Janusz K; Dębek W; Zoch-Zwierz W; Kuroczycka-Saniutycz E
Pediatr Nephrol; 2011 Apr; 26(4):579-86. PubMed ID: 21279810
[TBL] [Abstract][Full Text] [Related]
15. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as early biomarkers for predicting vancomycin-associated acute kidney injury: a prospective study.
Pang HM; Qin XL; Liu TT; Wei WX; Cheng DH; Lu H; Guo Q; Jing L
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4203-4213. PubMed ID: 29028077
[TBL] [Abstract][Full Text] [Related]
16. Reference intervals for renal injury biomarkers neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in young infants.
Zwiers AJ; de Wildt SN; de Rijke YB; Willemsen SP; Abdullahi NS; Tibboel D; Cransberg K
Clin Chem Lab Med; 2015 Jul; 53(8):1279-89. PubMed ID: 25720126
[TBL] [Abstract][Full Text] [Related]
17. Urinary neutrophil gelatinase-associated lipocalin identifies critically ill young children with acute kidney injury following intensive care admission: a prospective cohort study.
Zwiers AJ; de Wildt SN; van Rosmalen J; de Rijke YB; Buijs EA; Tibboel D; Cransberg K
Crit Care; 2015 Apr; 19(1):181. PubMed ID: 25895828
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic and prognostic values of serum and urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin in sepsis induced acute renal injury patients.
Zhang CF; Wang HJ; Tong ZH; Zhang C; Wang YS; Yang HQ; Gao RY; Shi HZ
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5604-5617. PubMed ID: 32495895
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil gelatinase-associated lipocalin (NGAL) predicts the occurrence of malaria-induced acute kidney injury.
van Wolfswinkel ME; Koopmans LC; Hesselink DA; Hoorn EJ; Koelewijn R; van Hellemond JJ; van Genderen PJ
Malar J; 2016 Sep; 15(1):464. PubMed ID: 27612570
[TBL] [Abstract][Full Text] [Related]
20. Role of urinary NGAL and KIM-1 as biomarkers of early kidney injury in obese prepubertal children.
Polidori N; Giannini C; Salvatore R; Pelliccia P; Parisi A; Chiarelli F; Mohn A
J Pediatr Endocrinol Metab; 2020 Sep; 33(9):1183-1189. PubMed ID: 32845866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
